New weapons – and precautions – as controls lifted on COVID ‘magic bullets’

From Thursday (September 1), COVID-19 patients can buy prescription antiviral medicines from pharmacies, as authorities ease access to weapons against the virus. “Health agencies are offering easier access to these…

Read More

Thailand prepares armory of anti-COVID weapons for Songkran battle 

With the number of COVID-19 patients surging to more than 20,000 daily, Thai authorities are busy taking steps to ensure an adequate supply of medicines. Even though most COVID-19 patients…

Read More

Thailand signs deal with Pfizer to supply 2 million anti-viral Paxlovid tablets

The Thai Medical Services Department signed an agreement with Pfizer (Thailand) today (Thursday) to procure 50,000 courses (2 million tablets) of the Paxlovid anti-viral medicine for the treatment of COVID-19….

Read More
Tiktok: praewzim

Thai woman’s eye colour turns indigo after taking Favipiravir

A Thai woman posted a clip on Tiktok on Wednesday, which shows her eye colour has turned an odd shade of indigo after taking medication for treatment of COVID-19, prompting…

Read More
“AFP PHOTO /Merck & Co,Inc./HANDOUT”

Thailand signs ฿500m deal to buy 50,000 courses of Molnupiravir COVID-19 medication

Thailand’s Medical Services Department signed a 500-million baht deal with MSD (Thailand) today (Thursday) to buy 50,000 courses of Merck’s Molnupiravir (Lagevrio) oral anti-viral medication for the treatment of COVID-19…

Read More
Photo from AP

Thailand not eligible to produce generic Molnupiravir anti-viral drug

Thailand is not eligible to produce a generic version of Merck’s Molnupiravir anti-viral drug, which is shown to reduce hospitalisations and deaths among COVID-19 patients by 50%, because it is…

Read More

Nine arrested in Thailand for selling Favipiravir online without permission

Nine people, including the general manager of a private hospital in Thailand, have been arrested by officers from the Consumer Protection Police Division for allegedly selling the anti-viral drug Favipiravir…

Read More

CCSA approves plan to buy 50,000 courses of anti-viral Molnupiravir drug

Thailand’s Centre for COVID-19 Situation Administration (CCSA) today (Thursday) approved the Public Health Ministry’s proposal to procure 50,000 courses of the anti-viral Molnupiravir drug, made by US pharmaceutical company Merck. …

Read More

Page 1 of 1


Welcome! Login in to your account

Remember me Lost your password?

Lost Password